Asciminib

Asciminib is a groundbreaking targeted therapy for chronic myeloid leukemia (CML), offering patients improved outcomes with fewer side effects. Its unique mechanism inhibits BCR-ABL1 effectively. Discover how Asciminib revolutionizes CML treatment; consult your doctor today to explore this innovative option!